European Journal of Nuclear Medicine and Molecular Imaging (2026). | Tina Nazerani-Zemann et al.
Scintigraphy using 99mTc-labeled bone-seeking tracers is a cornerstone in the non-invasive diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). However, planar imaging alone, particularly in patients...
Journal of the American Society of Echocardiography | Bjornar Grenne et al.
Few areas in cardiovascular imaging have changed as much over the past decade as the recognition and diagnosis of transthyretin cardiac amyloidosis (ATTR-CA). What was once regarded largely as an uncommon...
European Journal of Heart Failure (2026). | Fontana Marianna et al.
Acoramidis, an oral transthyretin stabilizer that achieves near-complete (≥90%) transthyretin stabilization, demonstrated significant clinical benefit over placebo in participants with transthyretin...
By requesting access to the "ATTR Expert" service, I agree that GNM Healthcare Consulting France SAS may use the data acquired during my access request to provide me with twice per month
information related to its services in accordance with the
Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to
dpo@gnmhealthcare.com.
You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.
